Тable 9 | Expectorated sputum volume (ml) in both groups during 5 days of treatment
4-very much so, 3- probably yes, 2- not much, 1- not at all
Patient
1
2
3
4
5
6
7
8
9
10
Group Day 1
100
80
40
55
40
70
60
70
70
35
80
60
40
50
30
50
50
60
40
30
80
55
30
40
25
25
40
50
40
20
60
45
20
35
25
20
30
40
40
15
50
40
20
30
25
20
20
35
35
15
2
2
2
1.8
1.6
3.5
3
2
2
2.3
Day 2 Day 3 Day 4 Day 5
Expectorated sputum volume decrease in 5
days therapy: Х times
Simeox
Simeox
Simeox
Simeox
Simeox
Control
Control
Control
Control
Control
The Study (Simeox) group patients have pointed out the ease of training and the convenience of use of the device, all of them
gave a positive answer to the question if they could use the device at home and if they would recommend this technique to
another patient.
Conclusion
The pilot study of Simeox physiotherapy in adult Cystic Fibrosis patients has demonstrated safety, feasibility and positive
airway clearance effect in clinical setting.
On the Day 1 of treatment the expectorated sputum volume (Med, IQR) in the Study group was -55.0 (50.0) ml, in the Control
group -70.0 (22.5) ml. (Table 9).
On the Day 5 of treatment the expectorated sputum volume (Med, IQR) was 30.0 (22.5) ml in the study group, in the Control
group 20.0 (20.0) ml, p=0.243.
The expectorated sputum volume in the Study group decreased 2.0 (0.28) times, it is significantly lower (p=0.034) than in the
Control group, where the sputum volume decreased 2.3 (1.25) times.
17
